News

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.
Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...
The Executive Director of the Ghana Foundation for Sickle Gene Action, Victoria Awo Twumasi, has called on President John Dramani Mahama to include full coverage of sickle cell disease treatment under ...
Democratic Sen. Catherine Cortez Masto is warning Nevadans that President Donald Trump’s spending and tax cut bill will ripple through every aspect of the state’s health care system, going far beyond ...
A delay, as opposed to a firm stagnation, then, but one unfolding over several years. This applies not only to SMEs, but to big pharma, too, in terms of restructuring and refocusing – even in terms of ...
"I went from a minor toothache to almost dead in about three days. So any time I hear someone question whether or not to get ...
The ability to analyze gene expression at the single-cell level—known as single-cell RNA sequencing (scRNA-seq)—has ...
Some highlights of the most significant milestones in the history of the NHS. 1948 NHS is born, providing healthcare services that are free for all at the point of delivery 1949 Ministries of Health ...
Vertex Pharmaceuticals unveiled impressive long-term results for its CRISPR/Cas9 gene therapy, PrCASGEVY, at the EHA Congress ...
Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...
A minor blood group incompatibility with anti-c caused severe hemolytic disease of the fetus and newborn even without ABO or ...
Some proposals would strip coverage from people who are unable to find employment — even though being healthy is essential to searching, interviewing, obtaining, and keeping a job. While cutting ...